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ABSTRACT 
Objective: To validate the factor structure of two common self-report depression tools in a 
large sample of haemodialysis (HD) patients and to examine their demographic and clinical 
correlates, including urine output, history of depression and transplantation.  
Methods: Factor structures of the Beck Depression Inventory (BDI-II) and Patient Health 
Questionnaire (PHQ-9) were evaluated using confirmatory factor analysis (CFA). Data was 
utilised from the screening phase (n=709) of a placebo-controlled feasibility randomised 
control trial (RCT) of sertraline in HD patients with mild to moderate Major Depressive 
Disorder. Alternative factor models including bi-factor models for the BDI-II and PHQ-9 were 
evaluated. Coefficient omega and omega-hierarchical were calculated. 
Results: For both measures, bi-factor measurement models had the overall best fit to the data, 
with dominant general depression factors. Omega-hierarchical for the general BDI-II and PHQ-
9 factors was 0.94 and 0.88 respectively. Both general factors had high reliability (coefficient 
omega = 0.97 and 0.94 respectively) and explained over 85% of the explained common 
variance within their respective models. BDI-II and PHQ-9 general depression factors were 
negatively associated with age and urine output and positively with a history of depression, 
antidepressant use within the last 3 months, and a history of failed transplantation. In adjusted 
regression models, age, urine output and a history of depression remained significant. 
Conclusions: These data suggest that both the BDI-II and PHQ-9 are sufficiently 
unidimensional to warrant the use of a total score. Younger age, lower urine output and a 
history depression appear consistent correlates of depression severity among HD patients. 
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INTRODUCTION 
Efforts to develop a core set of outcomes for haemodialysis (HD) trials are well underway with 
both clinical and patient reported outcomes being identified as important [1]. It is well 
established that depression remains one of the most common symptoms among individuals 
with End-Stage Kidney Failure (ESKF), with 30-40% of patients experiencing significant 
depressive symptomology [2]. Depression symptoms are associated with adverse outcomes 
among dialysis patients with increased mortality being the most consistently reported [3–5]. 
Evaluating which self-report depression tools are most suited for regular screening and serving 
as appropriate outcome measures in intervention trials is therefore warranted.  
Two depression measures, the Beck Depression Inventory (BDI-II) [6] and the Patient 
Health Questionnaire-9 (PHQ-9) [7], have been commonly used to evaluate depression 
symptoms among HD patients. Whilst these measures appear valid within this clinical 
population, only a few studies in dialysis patients have examined their underlying factor 
structures [8,9]. Within the renal literature there remains a tendency to consider 
cognitive/affective symptoms vs. somatic symptoms of depression, in an attempt to try and 
separate physical symptoms that might overlap with kidney disease. Despite this rationale to 
reduce criterion contamination, physical and cognitive/affective symptoms often correlate 
highly. Given this, bi-factor measurement models might be more appropriate in this setting, 
allowing underlying general and subgroup depression factors to be identified and used in 
research as outcome measures.  
Within kidney patients, two studies have reported that for both the BDI-II and PHQ-9, 
bi-factor measurement models provide the best fitting and most conceptually acceptable 
interpretation [10,11]. In both of these studies, the general depression factors explained over 
73% and 81% of the common variance between items for the PHQ-9 and BDI-II respectively, 
with smaller subgroup cognitive and somatic factors explaining less than 10% of the explained 
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variance. From this data it would appear that both tools are sufficiently unidimensional to 
warrant the use of a total severity depression score. However, further evaluation of these 
screening tools is warranted in order to better understand their psychometric performance in 
kidney patients and identify appropriate underlying latent factors. Accordingly, the aim of this 
study was to examine the underlying latent factor structures of the BDI-II and PHQ-9 in a large 
sample of HD patients using Confirmatory Factor Analysis (CFA). Depression screening data 
used to select patients into a multicentre placebo controlled feasibility randomised control trial 
(RCT) of sertraline in HD patients with mild to moderate Major Depressive Disorder [12,13] 
was used here. In line with past findings we hypothesized that bi-factor models, with dominant 
general depression factors would provide the best fitting and most appropriate interpretation of 
the BDI-II and PHQ-9. Since this was a secondary data analysis, we also had the opportunity 
to explore demographic and clinical correlates of the identified latent depression factors. 
 
MATERIALS AND METHODS 
Design: BDI-II and PHQ-9 depression screening data (n=709) used to select patients into a 
multicentre placebo controlled feasibility randomised control trial (RCT) of sertraline in HD 
patients with mild to moderate Major Depressive Disorder [12,13] were analysed here (trial 
registration number: ISRCTN06146268). 
 
Patients: Prevalent HD patients treated across five UK dialysis centres were screened for 
depression using both the BDI-II and PHQ-9. Patients were eligible for screening providing 
they had been receiving HD for at least 3 months, were over 18 years of age and could speak 
and read English well enough to complete the screening measures. 1353 patients were 
approached for depression screening, with 243 excluded due to inability to read or understand 
English. Of the remaining 1110, 64% consented to be screened (n=709). The majority of the 
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sample was male (63.3%) with a median dialysis vintage of 33 months (inter quartile range = 
59). The average age was 64.1 (16.4) years. Mean depression scores at screening were 13.5 
(s.d= 11.4) and 6.9 (s.d=6.2) for the BDI-II and PHQ-9 respectively. 33% (95% confidence 
interval 30 – 37) had a BDI-II ≥16 and 28 % (95% confidence interval 25 – 31) scored ≥ 10 on 
the PHQ-9. A self-reported past history of depression was noted in 25% of patients. 
Antidepressant use within the 3 months prior to screening was 11%. 16% of the sample had at 
least one failed transplant, with the remaining 84% with no history of transplantation. A 
summary of clinical factors is provided in table 1. 
 
Clinical and demographic factors:  Presence of comorbidities (diabetes, heart disease, stroke, 
cancer, limb amputation, liver disease, lung disease), dialysis vintage (length of time on HD, 
months), haemoglobin (g/L), serum albumin (g/L), the number of past transplants (actual 
number and recoded as history of failed transplantation yes=1/no=0), urine output (passing 
more than cup per day; self-reported yes=1/no=1) and dialysis treatment adequacy (Kt/V) were 
collected from medical records. C-reactive protein (CRP, mg/L) was only available in a subset 
of the sample (n=396) since it is not commonly measured as part of routine practice. Due to its 
skewed distribution it was handled here as categorical variable using a clinical cut-off (CRP>5 
mg/L). Self-reported clinical history of depression and antidepressant use within the last 3 
months (on an antidepressant or not) was collected via a research nurse and was coded as yes=1, 
and no=1 for both variables. Demographic factors were collected from a questionnaire 
including age, gender and ethnicity (white vs. non-white).  
 
Statistical analysis: CFA was used to evaluate the factor structures of the BDI-II and 
PHQ-9 using Weighted Least-Squares with Mean and Variance adjustment (WLSMV) 
estimation. Missing data was small (less than 2% for all items). Given this and the estimator 
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used (WLSMV) available case data was used in the models. Alternative one, two and bi-factor 
models were tested for both measures. In the bi-factor PHQ-9 model, all 9 items were loaded 
onto a general depression factor (figure 1). Two smaller group factors – somatic (3-items) and 
affective/cognitive (6-items) were also specified. Correlations between all latent factors were 
fixed to zero and variances of the latent factors fixed. A two factor PHQ-9 model comprising 
of correlated physical (3-items) and cognitive/somatic factors (6-items) was tested, in line with 
past analyses of the PHQ-9 in other clinical settings [14]. A one factor PHQ-9 model was also 
evaluated with all items loaded onto a single depression factor. 
A bi-factor BDI-II model based upon Ward [15], and supported in past studies of HD 
[10] and myocardial infarction patients [16], was tested (figure 2). This model contains a 
general factor with all 21 items loaded upon it, and two smaller cognitive (8 items) and somatic 
(5 items) group factors. A two factor BDI-II model comprising of correlated cognitive-affective 
and somatic factors was also evaluated [6]. A one factor model was also evaluated with all 
items loaded onto a single depression factor. 
Assessment of goodness-of-fit was based upon a confirmatory fit index (CFI) >.95, root 
mean squared error of approximation (RMSEA) <.08, and the Tucker-Lewis index (TLI) >.95 
[17]. Reliability of the total and subscale scores was assessed using the omega index 
(coefficient omega [w]), accompanied by omega-hierarchical, which is an indicator of the 
saturation of a multidimensional scale by a general factor [18,19]. For the subgroup factors 
relative omega was computed which controls for the part of the reliability attributable to the 
general factor. Demographic and clinical correlates of the identified general latent depression 
factors were also explored using univariate correlational analysis. Variables that demonstrated 
a significant univariate association with the general latent depression factors were then 
examined together in adjusted regression models which also controlled for gender and dialysis 
vintage. For these adjusted regression models unstandardized and standardised model 
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coefficients are presented accompanied by 95% confidence intervals (CI). The same adjusted 
models were rerun for the cognitive/affective and somatic subgroup factors for both the BDI-
II and PHQ-9. All analyses were conducted in MPlus version 7.3.  
 
RESULTS 
CFA: A summary of competing factor models for the BDI-II and PHQ-9 is shown in 
table 2. The correlation between the cognitive/affective and somatic factors was high within 
both measures (BDI-II r=0.85, p<0.01; PHQ-9 r=0.89, p<0.01). All of the examined factor 
models had relatively good fit, with the bi-factor models having marginally better fit as 
indicated by their fit indices. Figures 1 and 2 show the bi-factor models for the BDI-II and 
PHQ-9 respectively, accompanied by their standardised factor loadings (with standard errors). 
All factor loadings on the general factor were above 0.50 and all factor loadings across the 
general and subgroup factors were significant (all p-values £0.01). 
For the BDI-II the general factor accounted for 88% of the explained common variance 
and had high reliability (coefficient omega = 0.97). The smaller subgroup cognitive and 
somatic factors accounted for 6.0% and 5.0% of the explained variance respectively. Reliability 
of the subgroup factors was high (coefficient omega = 0.92 and 0.95 respectively), reducing to 
0.12 and 0.15 after controlling for the part of the reliability attributable to the general 
depression factor. Omega-h for the general depression factor was 0.94 indicating that the total 
score across all items included in the scale predominantly reflects a general depression factor. 
The general PHQ-9 factor accounted for 85% of the explained common variance and 
had high reliability (coefficient omega = 0.94). The subgroup cognitive/affective and somatic 
factors accounted for 11.3% and 3.4 % of the explained variance respectively, and also had 
high reliabilities (coefficient omega = 0.93 and 0.79 respectively). After controlling for the part 
of the reliability attributable to the general depression factor the subgroup coefficients drop to 
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0.11 and .10, respectively. Omega hierarchical was 0.88, again indicating that for the PHQ-9, 
the total score across all items predominantly reflects a general depression factor. 
In summary, these data suggest that both the BDI-II and PHQ-9 are sufficiently 
unidimensional to warrant the use of a total score. As expected both general latent factors 
correlated highly (r=0.9, p<0.01).  
 
Correlates of the BDI-II and PHQ-9 general factors: 
Both general factors negatively correlated with age (standardized estimate 
[correlation]= -0.24, p<0.01 and -0.184, p<0.01). Urine output was negatively associated with 
both general depression factors (see table 3).  A self-reported history of depression, having had 
a failed transplant and antidepressant use during the past 3 months were all positively 
associated with both general depression factors (table 3). Neither depression general factor was 
associated with gender, ethnicity, comorbidities, Haemoglobin, serum albumin, CRP>5 mg/L, 
dialysis vintage, the number of past transplants and Kt/V.  
In adjusted regression models that controlled for all the variables shown in table 3 and 
also gender and dialysis vintage; age, urine output and a self-reported history of depression 
remained significantly associated with both general factors.  
 
Correlates of the BDI-II and PHQ-9 subgroup factors: 
The cognitive/affective and somatic subgroup factors from both the BDI-II and PHQ-9 
were regressed upon the variables shown in table 3 (in separate analyses for both measures). 
For the BDI-II, the adjusted models revealed significant associations between the 
cognitive/affective subgroup factor with age (unstandardized estimate = -0.04, 95% CI -0.05, 
-0.02; p<0.01) and a past history of depression (unstandardized estimate = 1.9, 95% CI 1.30, 
2.50; p<0.01) but not with failed transplantation, antidepressant use or urine output. The 
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somatic subgroup factor was associated with urine output (unstandardized estimate = -0.60, 
95% CI -0.92, -0.27; p<0.01) and a past history of depression (unstandardized estimate = 0.96, 
95% CI 0.48, 1.43 p<0.01) but not with failed transplantation, antidepressant use or age.  
For the PHQ-9, the somatic subgroup factor was only associated with past history of 
depression (unstandardized estimate =0.62, 95% CI 0.36, 0.89; p<0.01). The 
cognitive/affective subgroup factor was associated with urine output (unstandardized estimate 
= -0.13, 95% CI -0.24, -0.02; p<0.05) and a past history of depression (unstandardized estimate 
= 0.34, 95% CI 0.21, 0.47 p<0.01).  
 
DISCUSSION 
Depression is uncontroversially present in a significant proportion of patients on haemodialysis 
[2]. Measuring depression routinely and offering appropriate evidenced based interventions is 
therefore a clinical priority. In an attempt to further evaluate two common depression screening 
tools, we found that both the BDI-II and PHQ-9 have dominant general depression factors and 
thus are sufficiently unidimensional to warrant a total severity score. These results support 
previous work [10,11] and suggest that both measures have high reliably for a general factor. 
Either measure would be suitable for regular depression screening among dialysis patients, or 
as outcome measures in clinical trials. The PHQ-9 might well be preferred for its relative 
brevity. If researchers and clinicians wish to have a broader measure of distress, then the Patient 
Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) [20] (which a composite 
measure of depression and anxiety symptoms using the Patient Health Questionnaire-9 and 
Generalised Anxiety Disorder Scale [21]) is recommended [11].  
 With regards to correlates of depression, our findings support past data revealing a 
negative relationship between age and depression symptoms among dialysis patients [22]. 
Furthermore, we observed an association between urine output and depression symptoms, 
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findings which replicate a smaller study which showed a negative association between residual 
renal function and depression symptoms among HD patients [23]. Patients passing less than 1 
cup of urine per day by their own estimate, had higher depressive symptoms than those passing 
more. This may reflect the restrictions imposed on the anuric patient in terms of diet and fluid 
intake, lack of any residual renal function and the potential for longer hours of dialysis and 
increased medication. Of course, this association could also be explained by increased somatic 
symptom reporting in anuric patients.  Analysis of the BDI-II subgroup factors partially support 
this explanation since urine output was associated with the somatic subgroup factor but not the 
cognitive/affective factor. However, the opposite was evident for the PHQ-9, where the 
cognitive/affective subgroup factor was associated with urine output but not the somatic factor. 
This could be the consequence of more somatic items featuring in the BDI-II. Taken together, 
the association observed between depression severity and urine output is likely the combination 
of increased somatic symptoms, greater dietary restrictions and treatment related impact. 
Although longitudinal studies are needed to further examine the relationship between urine 
output and mood in order to infer causality, it is possible that preserving residual function has 
some advantages beyond identified clinical outcomes [24]; possibly being beneficial for mental 
health.  
 Unsurprisingly having a history of depression was associated with increased depression 
symptoms in our sample, results with mirror findings in renal transplant recipients [25]. A 
novel finding of particular interest was the association between depression and failed 
transplantation. The impact of a failed previous transplant necessitating a return to dialysis on 
depressive symptoms has been infrequently reported before and only in small numbers [26], 
the return to haemodialysis especially after a short duration of graft function being associated 
with depression [27].The current study did not identify if patients had been transplanted pre-
emptively or had previously experienced dialysis, but the loss of a transplant had a significant 
Measuring self-reported depression in HD- author accepted manuscript – General Hospital Psychiatry 16/08/2018 
 
 11 
association with increased depressive symptoms. There are many potential reasons for this, 
loss of expectation, sense of failure, lack of future prospects for re-transplantation and 
additional complications arising from immunosuppression. However, this study did not 
differentiate between live donor recipients or deceased donor recipients, a previous study has 
shown that even with a functioning transplant recipients of a deceased donor kidney may 
exhibit more symptoms associated with depression than one from a live donor [28]. In adjusted 
analyses, the effect of failed transplantation was no longer significant, a likely result of failed 
transplantation being associated with a history of depression (odds ratio= 1.6, p=0.02). 
Accordingly, the process of returning to dialysis with a failing transplant and the point at which 
intervention into depressive symptoms is an area worth exploring further. 
This study has some key strengths which include a large sample size and overall 
completeness of data. However, limitations of this study include the lack of a full psychometric 
evaluation (including for example test retest validity and testing model invariance over time). 
Furthermore, the study was restricted to English speaking patients therefore limiting 
generalizability. Clinical histories of depression and antidepressant treatment were also self-
reported by the patients since it was not possible here to verify from clinical records. 
Furthermore, urine output was also self-reported. We also had limited available demographic 
information, missing potentially important data such as social economic status. Lastly, 
correlates of the latent depression general factor were explored cross-sectionally and were 
limited to clinical data collected from medical records therefore excluding other potentially 
important clinical and psychological factors [29].  
In conclusion the BDI-II and PHQ-9 are sufficiently unidimensional to warrant the use 
of a total depression score. Younger age, lower urine output and a clinical history of depression 
appear to be consistent correlates of depression severity among HD patient and should be 
considered risk factors in this population.  
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Table 1: Clinical characteristics.   
Variable Statistic 
Heart disease (%) 31.7 
Diabetes (%) 33.3 
Cancer (%) 10.6 
Liver disease (%) 2.4 
Lung disease (%) 6.4 
Amputation of limbs (%) 3.2 
Stroke (%) 8.0 
Haemoglobin  g/L (mean, s.d) 11.1 (1.2) 
Serum Albumin g/L (mean, s.d) 37.4 (4.4) 
Dry weight (mean, s.d, kg) 75.5 (18.3) 
CRP (>5 mg/L, %) 52% 
Kt/V (mean, s.d) 1.4 (0.3) 
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Table 2: Alternative CFA models for the BDI-II and PHQ-9 
Model Chi-square (df), p-value Number of free  
parameters 
CFI TLI RMSEA 
BDI-II      
 1-factor 835.7 (189), p<0.01 84 0.963 0.959 0.070 
 2-factor 633.1 (188), p<0.01 85 0.976 0.972 0.058 
 Bi-factor 420.9 (176), p<0.01 97 0.986 0.983 0.044 
PHQ-9      
 1-factor 129.2 (27), p<0.01 36 0.984 0.978 0.073 
 2-factor 92.6 (26), p<0.01 37 0.989 0.985 0.060 
 Bi-factor 37.0 (19), p<0.01 45 0.997 0.994 0.040 
 
Root mean squared error of approximation (RMSEA); Confirmatory Fit Index (CFI); Tucker-Lewis index 
(TLI); Degrees of freedom (df) 
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Table 3: Unadjusted and adjusted associations with the BDI-II and PHQ-9 general 
factors. 
 
 
 
Estimates shown are unstandardized with 95% confidence intervals in parentheses 
aadjusted for all the variables listed in the table and also dialysis vintage and gender. 
history of failed transplantation (no=0/yes=1); urine output (passing more than cup per day; self-
reported no=0/yes=1);  
Self-reported clinical history of depression (no=0/yes=1) and antidepressant use within the last 3 
months (on an antidepressant no=0/yes=1).  
*p<0.05 
*p<0.01 
 
 
 
 
 BDI-II general factor PHQ-9 general factor 
Variables Unadjusted Adjusteda Unadjusted Adjusteda 
Age (years) -4.0 (-5.30, -2.70)** -0.01 (-0.02, -0.01)** -3.0 (-4.3, -1.7)** -0.01 (-0.02, -0.01)* 
Urine output -0.14 (-0.24, -0.04)** -0.20 (-0.38, -0.01)* -0.18 (-0.28, -0.08)** -0.27 (-0.46, -0.08)** 
History of depression 0.54 (0.46, 0.63)** 0.80 (0.56, 1.01)** 0.49 (0.40, 0.58)** 0.75 (0.50, 1.0)** 
Anti-depressants use 0.46 (0.35, 0.58)** 0.25 (-0.08, 0.58) 0.41 (0.28, 0.53)** 0.13 (-0.21, 0.46) 
Failed transplant 0.19 (0.07, 0.31)** 0.10 (-0.22, 0.42) 0.16 (0.04, 0.29)* 0.10 (-0.22, 0.42) 
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Figure 1: BDI-II bi-factor model (cog: cognitive-affective; som: somatic; dep: general 
depression factor). Standardised estimates shown. 
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Figure 2: PHQ-9 bi-factor model (cog; cognitive; som: somatic; dep: general depression 
factor). Standardised estimates shown. 
 
